Measuring Neutralizing Ability to SARS-CoV-2 Variant Spike Proteins
ANALYSIS OF IMMUNE ESCAPE VARIANTS FROM ANTIBODY-BASED
Development of multivalent nanobodies blocking SARS-CoV-2
Frontiers SARS-CoV-2 and the Host Cell: A Tale of Interactions
A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell–derived allogeneic cell therapies - Cytotherapy
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding - ScienceDirect
High-throughput screening of spike variants uncovers the key
Antibody escape and cryptic cross-domain stabilization in the SARS
ACE2 – NIH Director's Blog
Rapid characterization of spike variants via mammalian cell surface display - ScienceDirect
